FDA Slaps Drug Co. Ad's Misleading

The FDA claims that MGI Pharma published a "misleading" advertisement for the company's implanted therapy to treat brain tumors.

A two-page promotional ad for the product, called gliadel wafer, does not disclose its full indication and presents unsubstantiated claims, according to the FDA.

For more, go here.